Want to join the conversation?
$FOSL 2Q15 PR: For 2015, the Company expects net sales to decrease in the range of 8% to 4%; operating margin to be in a range of 10.5% to 11.5% and diluted EPS to be $4.80 to $5.60. For 3Q15, the Company expects net sales to decrease in the range of 15% to 10%; operating margin to be in a range of 9.5% to 11% and diluted EPS to be $1.03 to $1.28.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?